RANI News and Press, Rani Therapeutics Holdings Inc. From 10/20/25

2025-10-20 05:32:24 ET More on related stocks: Plug Power's Black Cloud Addressed (Rating Downgrade) Plug Power: Sell On Unwarranted AI Data Center Hype Plug Power: Don't Ignore Operational Issues Rani Therapeutics surges on Chugai licensing deal, private pla...

A look at the top 10 most actives in the United States Rani Therapeutics Holdings Inc. (RANI) rose 248.3% to $1.64 on volume of 482,613,416 shares Beyond Meat Inc. (BYND) rose 24.2% to $0.6456 on volume of 419,584,353 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.0% to $4...

2025-10-17 15:25:49 ET DENVER, Colo., Oct 17, 2025 ( 247marketnews.com )- As the trading week hits the final stretch, the biotech sector has emerged as the clear market leader, with needle-free biologics , fast-track cell therapies , and strategic pivots dominating the headl...

2025-10-17 11:45:00 ET Rani Therapeutics (Nasdaq: RANI) Makes Nasdaq Top Gainer on $1.085 Billion Pharma Collaboration News Published on Oct 17, 2025 October 17, 2025- ( Investorideas.com Newswire), a go-to investing...

A look at the top 10 most actives in the United States Rani Therapeutics Holdings Inc. (RANI) rose 158.0% to $1.215 on volume of 150,083,425 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 3.9% to $4.175 on volume of 72,025,447 shares Bitfarms Ltd. (BITF) fell 8.5% to $4.83 o...

2025-10-17 09:56:27 ET More on Rani Therapeutics, Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript Rani Therapeutics secures $60.3M ...

2025-10-17 08:11:29 ET DENVER, Colo., Oct 17, 2025 ( 247marketnews.com )- Rani Therapeutics (NASDAQ:RANI), a clinical-stage biotech pioneering the oral delivery of biologics, surged into the spotlight today with the announcement of a potentially transformative partnership and an oversub...

2025-10-17 07:43:41 ET More on Rani Therapeutics Rani Therapeutics GAAP EPS of -$0.18 beats by $0.02 Seeking Alpha’s Quant Rating on Rani Therapeutics Historical earnings data for Rani Therapeutics Financial information for Rani Therapeutics ...

Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir Imran At the closing of the financing, each of Samsara and Anomaly will have the righ...

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $100 million in sales milestones and single digit royalties on product sales for the first license agreement Chugai has the option to exten...